S6K1−/−/S6K2−/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway
暂无分享,去创建一个
Stefano Fumagalli | George Thomas | J. Mestan | G. Thomas | M. Pende | S. Fumagalli | S. Kozma | S. Um | V. Mieulet | Melanie Sticker | V. Goss | Matthias Mueller | Mario Pende | Sung Hee Um | Virginie Mieulet | Melanie Sticker | Valerie L. Goss | Jurgen Mestan | Matthias Mueller | Sara C. Kozma | Virginie Mieulet
[1] Jennifer Skeen,et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. , 2003, Genes & development.
[2] J. Avruch,et al. The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif* , 2003, The Journal of Biological Chemistry.
[3] Rainer Cramer,et al. Protein Kinase C Phosphorylates Ribosomal Protein S6 Kinase βII and Regulates Its Subcellular Localization , 2003, Molecular and Cellular Biology.
[4] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[5] Hua Tang,et al. Transduction of Growth or Mitogenic Signals into Translational Activation of TOP mRNAs Is Fully Reliant on the Phosphatidylinositol 3-Kinase-Mediated Pathway but Requires neither S6K1 nor rpS6 Phosphorylation , 2002, Molecular and Cellular Biology.
[6] R. Abraham. Identification of TOR Signaling Complexes More TORC for the Cell Growth Engine , 2002, Cell.
[7] J. Avruch,et al. TOR Deficiency in C. elegans Causes Developmental Arrest and Intestinal Atrophy by Inhibition of mRNA Translation , 2002, Current Biology.
[8] J. Blenis,et al. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.
[9] E. Wang,et al. Nerve Growth Factor Specifically Stimulates Translation of Eukaryotic Elongation Factor 1A-1 (eEF1A-1) mRNA by Recruitment to Polyribosomes in PC12 Cells* , 2002, The Journal of Biological Chemistry.
[10] A. Jaeschke,et al. Mammalian TOR: A Homeostatic ATP Sensor , 2001, Science.
[11] C. Proud,et al. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.
[12] Philip R. Cohen,et al. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway , 2001, FEBS letters.
[13] A. Gingras,et al. Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.
[14] J. Blenis,et al. Regulation of Ribosomal S6 Kinase 2 by Effectors of the Phosphoinositide 3-Kinase Pathway* , 2001, The Journal of Biological Chemistry.
[15] S. Volarevic,et al. Role of S6 phosphorylation and S6 kinase in cell growth. , 2001, Progress in nucleic acid research and molecular biology.
[16] R. Burcelin,et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice , 2000, Nature.
[17] Tobias Schmelzle,et al. TOR, a Central Controller of Cell Growth , 2000, Cell.
[18] S. Gammeltoft,et al. A phosphoserine‐regulated docking site in the protein kinase RSK2 that recruits and activates PDK1 , 2000, The EMBO journal.
[19] G. Thomas. An encore for ribosome biogenesis in the control of cell proliferation , 2000, Nature Cell Biology.
[20] N. Sonenberg,et al. Translational control of gene expression , 2000 .
[21] Kenta Hara,et al. Immunopurified Mammalian Target of Rapamycin Phosphorylates and Activates p70 S6 Kinase α in Vitro * , 1999, The Journal of Biological Chemistry.
[22] E. Hafen,et al. Drosophila S6 kinase: a regulator of cell size. , 1999, Science.
[23] J. Blenis,et al. Characterization of S6K2, a novel kinase homologous to S6K1 , 1999, Oncogene.
[24] H. Koh,et al. Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); A novel nuclear target of Akt , 1999, Oncogene.
[25] S. Gammeltoft,et al. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction , 1999, Molecular and Cellular Endocrinology.
[26] G. Thomas,et al. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. , 1999, Current opinion in genetics & development.
[27] M. Schwab,et al. p70 S6K Controls Selective mRNA Translation during Oocyte Maturation and Early Embryogenesis in Xenopus laevis , 1999 .
[28] K. Miyazono,et al. Cloning and Characterization of p70S6KβDefines a Novel Family of p70 S6 Kinases , 1998 .
[29] Stefano Fumagalli,et al. Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.
[30] I. Gout,et al. Molecular Cloning and Characterization of a Novel p70 S6 Kinase, p70 S6 Kinase β Containing a Proline-rich Region* , 1998, The Journal of Biological Chemistry.
[31] S. Snyder,et al. Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] E. Gelfand,et al. Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Snyder,et al. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Andjelkovic,et al. Phosphorylation and activation of p70s6k by PDK1. , 1998, Science.
[35] A. Gingras,et al. The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k , 1997, Molecular and cellular biology.
[36] R. Pearson,et al. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k , 1997, The EMBO journal.
[37] A. Gavin,et al. Ribosomal S6 kinase p90rsk and mRNA cap‐binding protein eIF4E phosphorylations correlate with MAP kinase activation during meiotic reinitiation of mouse oocytes , 1997 .
[38] Minoru Hongo,et al. MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.
[39] A. Gavin,et al. Ribosomal S6 kinase p90rsk and mRNA cap-binding protein eIF4E phosphorylations correlate with MAP kinase activation during meiotic reinitiation of mouse oocytes. , 1997, Molecular reproduction and development.
[40] G. Thomas,et al. 14 Ribosomal Protein S6 Phosphorylation and Signal Transduction , 1996 .
[41] O. Meyuhas,et al. 13 Translational Control of Ribosomal Protein mRNAs in Eukaryotes , 1996 .
[42] Philip R. Cohen,et al. Comparison of the specificities of p70 S6 kinase and MAPKAP kinase‐1 identifies a relatively specific substrate for p70 S6 kinase: the N‐terminal kinase domain of MAPKAP kinase‐1 is essential for peptide phosphorylation , 1995, FEBS letters.
[43] A. Nairn,et al. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] G. Thomas,et al. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Fernández,et al. Nuclear localization of p85s6k: functional requirement for entry into S phase. , 1994, The EMBO journal.
[46] G. Thomas,et al. Elongation factor-1 alpha mRNA is selectively translated following mitogenic stimulation. , 1994, The Journal of biological chemistry.
[47] S. Ferrari,et al. Identification of 40 S ribosomal protein S6 phosphorylation sites in Swiss mouse 3T3 fibroblasts stimulated with serum. , 1993, The Journal of biological chemistry.
[48] G. Crabtree,et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase , 1992, Nature.
[49] J. Maller,et al. Ordered multisite phosphorylation of Xenopus ribosomal protein S6 by S6 kinase II. , 1992, The Journal of biological chemistry.
[50] M. Dorée,et al. Identification and early activation of a Xenopus laevis p70s6k following progesterone‐induced meiotic maturation. , 1992, The EMBO journal.
[51] J. Hofsteenge,et al. Mitogen-activated 70K S6 kinase. Identification of in vitro 40 S ribosomal S6 phosphorylation sites. , 1991, The Journal of biological chemistry.
[52] B. Hemmings,et al. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[53] S. Kozma,et al. Oncogenic activation of the human trk proto‐oncogene by recombination with the ribosomal large subunit protein L7a. , 1990, The EMBO journal.
[54] J. Maller,et al. In vivo phosphorylation and activation of ribosomal protein S6 kinases during Xenopus oocyte maturation. , 1989, The Journal of biological chemistry.
[55] J. Hofsteenge,et al. Identification of the 40 S ribosomal protein S6 phosphorylation sites induced by cycloheximide. , 1988, The Journal of biological chemistry.
[56] J. Maller,et al. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II , 1988, Nature.
[57] G. Thomas,et al. Differential regulation of S6 phosphorylation by insulin and epidermal growth factor in Swiss mouse 3T3 cells: insulin activation of type 1 phosphatase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[58] R. Lane,et al. High efficiency fusion procedure for producing monoclonal antibodies against weak immunogens. , 1986, Methods in enzymology.
[59] M. Spitz. "Single-shot" intrasplenic immunization for the production of monoclonal antibodies. , 1986, Methods in enzymology.
[60] J. Martín-Pérez,et al. Ordered phosphorylation of 40S ribosomal protein S6 after serum stimulation of quiescent 3T3 cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[61] P. Seglen. Preparation of isolated rat liver cells. , 1976, Methods in cell biology.